Bank of Nova Scotia’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-3,329
| Closed | -$371K | – | 988 |
|
|
2024
Q3 | $371K | Sell |
3,329
-18,771
| -85% | -$2.09M | ﹤0.01% | 875 |
|
|
2024
Q2 | $2.36M | Sell |
22,100
-24,913
| -53% | -$2.66M | ﹤0.01% | 601 |
|
|
2024
Q1 | $5.66M | Buy |
47,013
+35,860
| +322% | +$4.32M | 0.01% | 487 |
|
|
2023
Q4 | $1.37M | Buy |
11,153
+9,478
| +566% | +$1.17M | ﹤0.01% | 716 |
|
|
2023
Q3 | $217K | Sell |
1,675
-4,497
| -73% | -$582K | ﹤0.01% | 938 |
|
|
2023
Q2 | $765K | Buy |
6,172
+614
| +11% | +$76.1K | ﹤0.01% | 711 |
|
|
2023
Q1 | $813K | Buy |
5,558
+1,524
| +38% | +$223K | ﹤0.01% | 748 |
|
|
2022
Q4 | $643K | Sell |
4,034
-222,787
| -98% | -$35.5M | ﹤0.01% | 875 |
|
|
2022
Q3 | $30.2M | Buy |
226,821
+95,769
| +73% | +$12.8M | 0.1% | 173 |
|
|
2022
Q2 | $20.4M | Buy |
131,052
+96,728
| +282% | +$15.1M | 0.05% | 271 |
|
|
2022
Q1 | $5.34M | Sell |
34,324
-26,366
| -43% | -$4.1M | 0.01% | 576 |
|
|
2021
Q4 | $7.73M | Buy |
+60,690
| New | +$7.73M | 0.01% | 567 |
|
|
2020
Q3 | – | Sell |
-125,998
| Closed | -$13.9M | – | 1000 |
|
|
2020
Q2 | $13.9M | Buy |
+125,998
| New | +$13.9M | 0.05% | 258 |
|
|
2020
Q1 | – | Sell |
-19,000
| Closed | -$2.84M | – | 924 |
|
|
2019
Q4 | $2.84M | Buy |
+19,000
| New | +$2.84M | 0.01% | 630 |
|
|
2019
Q3 | – | Sell |
-23,064
| Closed | -$3.29M | – | 915 |
|
|
2019
Q2 | $3.29M | Buy |
23,064
+64
| +0.3% | +$9.12K | 0.01% | 505 |
|
|
2019
Q1 | $3.29M | Buy |
+23,000
| New | +$3.29M | 0.01% | 522 |
|
|
2018
Q4 | – | Sell |
-13,000
| Closed | -$2.19M | – | 850 |
|
|
2018
Q3 | $2.19M | Buy |
+13,000
| New | +$2.19M | 0.01% | 610 |
|
|
2016
Q4 | – | Sell |
-15,000
| Closed | -$1.82M | – | 797 |
|
|
2016
Q3 | $1.82M | Buy |
+15,000
| New | +$1.82M | 0.01% | 300 |
|